Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
However, PrEP still remains widely available, often provided via telemedicine.
Because of COVID-19, HIV testing nationwide has plummeted as much as 70%.
The U.S. Conference on HIV/AIDS aims to be a hub for HIV job openings, particularly jobs created to end the HIV epidemic.
New York collaborators will also address the related epidemics of hepatitis C, sexually transmitted infections and opioid use.
A 2018 report had suggested that HIV-positive women’s use of the drug at conception increased the risk of the rare birth defects.
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
Only 46% can trace the source of their infection—usually a family member or a coworker.
Pooled results from recent studies found a high rate of full viral suppression and no major safety concerns.
Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.
Two-drug antiretroviral regimens suppress viral load, but three-drug combos may offer additional benefits.
Competing conference HIV2020 offers the recommendations to help #ReclaimTheResponse and engage those affected by HIV.
The Supreme Court handed down two wins and a loss.
The novel attachment inhibitor led to viral suppression in 60% of people with extensive prior treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.